Effects of mobilisation of CD34-positive cells into the peripheral blood after Pegfilgrastim administration and their engraftment on post-transplantatio
Not Applicable
Recruiting
- Conditions
- Haematological malignancies (e.g. leukaemia, malignant lymphoma, multiple myeloma, myelodysplastic syndrome, myeloproliferative disorders)
- Registration Number
- JPRN-UMIN000054037
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
<Recipient>. 1 Persons who are considered to be at high risk of failure to thrive (as judged by the attending physician). 2 Other persons deemed unsuitable as research subjects by the principal investigator. <Donor 1 Persons who are deemed ineligible during the preoperative medical examination. 2 Other persons deemed unsuitable as research subjects by the principal investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method